Last reviewed · How we verify

Niacin and aspirin

Eastern Virginia Medical School · Phase 2 active Small molecule

Niacin and aspirin is a Small molecule drug developed by Eastern Virginia Medical School. It is currently in Phase 2 development. Also known as: Niaspan, Nicotinic acid.

At a glance

Generic nameNiacin and aspirin
Also known asNiaspan, Nicotinic acid
SponsorEastern Virginia Medical School
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Niacin and aspirin

What is Niacin and aspirin?

Niacin and aspirin is a Small molecule drug developed by Eastern Virginia Medical School.

Who makes Niacin and aspirin?

Niacin and aspirin is developed by Eastern Virginia Medical School (see full Eastern Virginia Medical School pipeline at /company/eastern-virginia-medical-school).

Is Niacin and aspirin also known as anything else?

Niacin and aspirin is also known as Niaspan, Nicotinic acid.

What development phase is Niacin and aspirin in?

Niacin and aspirin is in Phase 2.

Related